Zobrazeno 1 - 10
of 27
pro vyhledávání: '"G. E. Trivers"'
Autor:
Elise D. Bowman, James V. Lacey, Donna Perlmutter, Amy Berrington de Gonzalez, Alina V. Brenner, Raymond T. Jones, Sara J. Schonfeld, Curtis C. Harris, Christopher A. Loffredo, G. E. Trivers, Cari L. Meinhold
Publikováno v:
International Journal of Cancer. 128:1404-1413
Although exposure to estrogen may directly influence or modify the association between cigarette smoking and lung cancer risk, results from epidemiologic studies examining the association between reproductive and hormonal factors and risk of lung can
Autor:
Eilene Gruys, Ewy Mathé, Jonathan M. Weiss, Jeffery Subleski, Peijun He, Victor E. Laubach, Timothy C. Back, Diana C. Haines, Giang Nguyen, Draginja Djurickovic, Leah E. Mechanic, Robert H. Wiltrout, Curtis C. Harris, Lorne J. Hofseth, Mark E. Bernard, Anne B. Hofseth, G. E. Trivers, S. Perwez Hussain, Jonathan Schwank
Publikováno v:
Cancer Research. 68:7130-7136
Nitric oxide (NO•), an important signaling molecule and a component of inflammatory response, is involved in tumorigenesis. However, the quantity of NO• and the cellular microenvironment influences the role of NO• in tumor development. We used
Autor:
Marie J. Marion, Virna M. G. DeBenedetti, Helen L. Cawley, G. E. Trivers, Monica Hollstein, Curtis C. Harris, Carlo C. Tamburro, Marie L. Hoover, Carol C. Prives, William P. Bennett
Publikováno v:
JNCI Journal of the National Cancer Institute. 87:1400-1407
Background : The p53 tumor suppressor gene (also known as TP53) is often mutated in a wide variety of cancers, including angiosarcoma of the liver (ASL). Anti-p53 antibodies have been detected in the sera of patients with leukemia, childhood lymphoma
Autor:
G. E. Trivers, Peter G. Shields, Yu-Tang Gao, Y. H. Qu, WilliamJ. Blot, Curtis C. Harris, E. D. Pellizzari, J. F. Fraumeni, G. X. Xu
Publikováno v:
JNCI Journal of the National Cancer Institute. 87:836-841
Background : The lung cancer incidence in Chinese women is among the highest in the world, but tobacco smoking accounts for only a minority of the cancers. Epidemiologic investigations of lung cancer among Chinese women have implicated exposure to in
Autor:
Anthony J. Alberg, Curtis C. Harris, Yun-Ling Zheng, Leah E. Mechanic, Elise D. Bowman, Lindsey Enewold, Zhipeng Yu, G. E. Trivers
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(1)
Accumulating evidence suggests a role for inflammation in the development and progression of cancer. Our group recently identified a cytokine gene signature in lung tissue associated with lung cancer prognosis. Therefore, we hypothesized that concent
Autor:
Leah E. Mechanic, Kensuke Kumamoto, Nobutoshi Hagiwara, Elise D. Bowman, Curtis C. Harris, Hiroshi Makino, S. Perwez Hussain, Tsutomu Nomura, Masao Miyashita, Helen L. Cawley, Koji Sasajima, Takashi Tajiri, Peijun He, Ken Takahashi, Masataka Taga, Mark E. Bernard, G. E. Trivers, Saira Doja
Publikováno v:
Cancer research. 66(16)
In lung tumors, the p53 tumor suppressor gene is commonly mutated with a characteristic mutation spectrum. The amount of and alterations in plasma DNA, such as mutations in p53, were associated with several cancers. Few studies used quantitative meth
Autor:
Weston, A., Bowman, E. D., Povey, A. C., Manchester, D. K., Newman, M. J., Beland, G. E. Trivers. F. A., Farmer, P. B., Poirier, M. C., Harris, C. C.
Publikováno v:
Human Carcinogen Exposure: Biomonitoring and Risk Assessment.
Externí odkaz:
https://doi.org/10.1093/oso/9780199631858.003.0039
Autor:
R. F. Souza, M. C. Hollstein, S. J. Meltzer, A. Salabes, G. E. Trivers, H. M. Cawley, H. Bartsch, V. M. G. De Benedetti, William P. Bennett, B. D. Greenwald, J. Cottrell, K. R. Muehlbauer, L. Liang
Publikováno v:
Gastroenterology. 115(1)
We previously discovered anti-p53 antibodies predating a cancer diagnosis in subjects at increased risk for liver, lung, breast, and prostate cancer. Recently, we reported a significant correlation (P0.017) between p53 antibodies and p53 mutations in
Autor:
M C, von Brevern, M C, Hollstein, H M, Cawley, V M, De Benedetti, W P, Bennett, L, Liang, A G, He, S M, Zhu, T, Tursz, N, Janin, G E, Trivers
Publikováno v:
Cancer research. 56(21)
Serum antibodies reacting with the tumor suppressor protein p53 have been detected previously in cancer patients with a variety of neoplasms. Two initial (although insufficient) prerequisites for a B-cell response to occur have been proposed: p53 pro
Autor:
G E, Trivers, V M, De Benedetti, H L, Cawley, G, Caron, A M, Harrington, W P, Bennett, J R, Jett, T V, Colby, H, Tazelaar, P, Pairolero, R D, Miller, C C, Harris
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 2(10)
Serum anti-p53 antibodies (p53-Abs) may be surrogate markers for both p53 alterations and preclinical cancer. Ancillary to a prospective trial to abate progressive development of clinical stages of chronic obstructive pulmonary disease, we conducted